Successful treatment of severe Pneumocystis pneumonia in an immunosuppressed patient using caspofungin combined with clindamycin: a case report and literature review

BACKGROUND: Pneumocystis jirovecii is responsible for Pneumocystis pneumonia (PCP), which occurs almost exclusively in immunocompromised individuals. Trimethoprim-sulfamethoxazole (TMP-SMZ) is regarded as the first-line treatment and prophylaxis for P. jirovecii infection, but the frequency of adver...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hongjuan, Huang, Haoming, He, Hangyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106782/
https://www.ncbi.nlm.nih.gov/pubmed/27835947
http://dx.doi.org/10.1186/s12890-016-0307-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106782/
https://www.ncbi.nlm.nih.gov/pubmed/27835947
http://dx.doi.org/10.1186/s12890-016-0307-0

Ejemplares similares